Straumann Holding AG

QS50

Company Profile

  • Business description

    Straumann is a global leader in tooth replacement and orthodontics solutions. Its line of products includes dental implants, abutments, clear aligners, biomaterials, and computer-aided design/computer-aided manufacturing equipment. The firm's core products are dental implants, and it holds over one third of the CHF 6 billion global market. Originally a pure premium implant player, Straumann entered the value market in 2012 with its acquisition of Neodent. Straumann now accounts for almost half of the global premium market and around 15% of the value market. While its premium product catalog is marketed under Straumann, its value brands include Neodent, Anthogyr, and Medentika as well as other local and regional brands.

  • Contact

    Peter Merian-Weg 12
    Basel4002
    CHE

    T: +41 619651111

    E: [email protected]

    https://www.straumann-group.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Instruments & Supplies

    Fiscal Year End

    31 December 2026

    Employees

    11,948

Stocks News & Analysis

stocks

Lower fair value on ASX best idea

Shares are still undervalued despite drop in profit margins.
stocks

We raise our near-term gold price assumptions

Our coverage remains overvalued.
stocks

Apple: Gemini partnership lets AI-worried investors breathe a sigh of relief

We believe a competitive—if not leading—AI feature suite will reinforce Apple’s wide-moat mobile device ecosystem.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,184.2027.30-0.30%
CAC 408,304.3526.61-0.32%
DAX 4025,254.2831.96-0.13%
Dow JONES (US)49,149.6342.36-0.09%
FTSE 10010,225.9341.580.41%
HKSE26,923.6276.19-0.28%
NASDAQ23,471.75238.13-1.00%
Nikkei 22554,110.50230.73-0.42%
NZX 50 Index13,659.7997.92-0.71%
S&P 5006,926.6037.14-0.53%
S&P/ASX 2008,861.7019.30-0.22%
SSE Composite Index4,112.6013.49-0.33%

Market Movers